NEUROCRINE BIOSCIENCES INC (NBIX) › Total LiabilitiesNEUROCRINE BIOSCIENCES INC (NBIX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $125.08M2011: $78.29M2012: $41.61M2013: $34.27M2014: $34.33M2015: $50.33M2016: $50.21M2017: $445.45M2018: $512.39M2019: $669.10M2020: $608.50M2021: $698.50M2022: $660.90M2023: $1.02B2024: $1.13B2025: $1.38B$1.38B2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$1.38B+22.1%2024$1.13B+10.8%2023$1.02B+54.2%2022$660.90M-5.4%2021$698.50M+14.8%2020$608.50M-9.1%2019$669.10M+30.6%2018$512.39M+15.0%2017$445.45M+787.2%2016$50.21M-0.2%2015$50.33M+46.6%2014$34.33M+0.2%2013$34.27M-17.6%2012$41.61M-46.9%2011$78.29M-37.4%2010$125.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share